APD earnings
Air Products & Chemicals, Inc. — automated research on every print, the model's read of every earnings call, and the numbers against estimates.
| Reported | EPS | Consensus | Surprise |
|---|---|---|---|
| Jul 30, 2026 | 3.47 | 3.34 | +3.9% |
| Apr 30, 2026 | 3.20 | 3.06 | +4.6% |
| Jan 30, 2026 | 3.16 | 3.04 | +3.9% |
| Nov 06, 2025 | 3.39 | 3.38 | +0.3% |
Air Products & Chemicals, Inc. reported results (Jul 30, 2026). EPS came in at $3.47 against a $3.34 consensus, beat by 3.9%. Revenue was $3.2B versus $3.2B expected, missed by 1.3%.
read the full report →Air Products & Chemicals, Inc. (APD) reported a solid Q2 FY2026, beating both revenue and EPS estimates. The company's EPS of $3.20 exceeded the street estimate of $3.06 by 4.6%, while revenue of $3.17 billion surpassed the estimate of $3.07 billion by 3.3%. This performance, coupled with raised guidance and a significant reduction in capital expenditures, positions APD for continued growth and improved financial health.
read the full report →Air Products & Chemicals, Inc. cleared a low bar with EPS upside, but the variant read is that the market should pay more attention to the capital-intensity pivot than the +1.7% revenue surprise. The print supports earnings resilience in a weak macro tape, while the unresolved Louisiana derisking path keeps the stock from deserving a full re-rate until Q2 guidance and the $4 billion CapEx plan hold together.
read the full report →Air Products & Chemicals, Inc. delivered a near-in-line Q4 FY2025, but the actionable read is that FY2026 guidance is being built on cost takeout and project rationalization while capital intensity is moving higher, not lower. The market likely priced in EPS stability after the portfolio cleanup; it did not price in the combination of a $4 billion FY2026 capex requirement, a still-soft Q4 revenue base, and a management tone profile showing higher uncertainty into the next leg of backlog execution.
read the full report →Air Products & Chemicals, Inc. cleared a low bar with $3.09 EPS and $3,022.7 million of revenue, but the market’s likely mistake is treating the quarter as a cyclical gases recovery. The actionable read is narrower and more durable: pricing, cost-out, and capital discipline are beginning to matter more than project noise, and that shifts the debate from “when does growth reaccelerate?” to “how much of the $185 million to $195 million savings pool can drop through while revenue stays around $3.0 billion?”
read the full report →- Sees Q3 earnings per share $3.25 to $3.35.
- Sees 2026 earnings per share $13.00 to $13.25.
- Sees 2026 capital expenditures of about $4 billion.
- Sees 2026 capital expenditures about $1 billion lower than prior year.
- Sees 2026 earnings per share growth of 8% to 10%.